Advertisement

Topics

ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions.

02:17 EST 9 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Amsterdam, The Netherlands - 9 November 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the Tenth Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the ...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "ESPERITE (ESP) : L1 Capital subscribes to the Tenth tranche of investment today and shows confidence by investing additionally EUR 250K under the same conditions."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...